RecruitingPhase 4NCT07193277

Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy

Studying Cap myopathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
First Affiliated Hospital of Wenzhou Medical University
Principal Investigator
Huiqin Xu, MD
Department of Neurology, First Affiliated Hospital of Wenzhou Medical University
Intervention
Butylphthalide(drug)
Enrollment
220 enrolled
Eligibility
60-85 years · All sexes
Timeline
2025 – 2028

Study locations (1)

Collaborators

Taizhou Hospital · Lishui Country People's Hospital · Affiliated Yueqing Hospital of Wenzhou Medical University · The Third Affiliated Hospital of Wenzhou Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07193277 on ClinicalTrials.gov

Other trials for Cap myopathy

Additional recruiting or active studies for the same condition.

See all trials for Cap myopathy →

← Back to all trials